Press Release

« Back

Travere Therapeutics to Present at Upcoming Investor Conferences

Nov 11, 2021

SAN DIEGO, Nov. 11, 2021 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that management will present a Company overview at the following upcoming virtual investor conferences in November:

Jefferies 2021 London Healthcare Conference
Date: Thursday, November 18, 2021
Time: On-demand webcast available beginning 8:00 a.m. GMT (3:00 a.m. ET)

4th Annual Evercore ISI HealthCONx Conference
Date: Tuesday, November 30, 2021
Time: 10:30 a.m. ET

Live webcasts will be available at https://ir.travere.com/events-presentations and archived replays will be accessible for up to 30 days.

About Travere Therapeutics

At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com

Contact:
Chris Cline, CFA                                 
Senior Vice President, Investor Relations & Corporate Communications
888-969-7879                                        
IR@travere.com     

 


Primary Logo

Source: Travere Therapeutics, Inc.